NeoGenomics
在场
NeoGenomics 是一家在股票代码 NEO (US) 下上市的公司。
高管
查看带有其 31 名主要高管的组织结构图
NeoGenomics 搜索最多的简介
- Chris Smith, Chief Executive Officer and Director
- Lynn Tetrault, Non-Executive Chairman of the Board
- Alison Hannah, Director
高管在NeoGenomics变化
- Felicia Williams已作为Member of the Board加入公司 (新闻发布的2024十一月5号).
- Vishal Sikri, President, Advanced Diagnostics Division 请很快离开公司 (新闻发布的2024四月21号).
- Warren Stone 曾任 President, Clinical Division, 现升职为 Chief Commercial Officer (新闻发布的2024四月19号).
创建提醒
跟踪 NeoGenomics 的高管变动
健康
NeoGenomics 拥有 1,982 家竞争者，其中包括 UnitedHealth Group (美国(美洲))、UnitedHealthcare (美国(美洲)) 和 Siemens Healthineers (德国)。
Popular M&A news in 健康
- Oura Health 刚刚宣布为 200 筹款数百万美元。 (公布2024十二月20号).
- Neuronetics 已收购 Greenbrook TMS (公布2024十二月10号).
- Cleerly 刚刚宣布为 106 筹款数百万美元。 (公布2024十二月9号).
健康 行业的其他推荐联系人
消息
NeoGenomics 的最新新闻稿
- NeoGenomics’ Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma
- NeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual Meeting
- NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment
- Press Release | NeoGenomics Laboratories
- Felicia Williams Joins NeoGenomics Board of Directors
- NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference
- NeoGenomics Reports Third Quarter 2024 Results
- NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor Test
- NeoGenomics to Report Third Quarter 2024 Financial Results on Nov. 5, 2024
- NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid Leukemia
- View more press releases Close
关于 NeoGenomics 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Chris Smith 
